Comparison of Cyclosporine and Betamethasone Minipulse Therapy in Management of Alopecia Areata
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
Studysummary This study found that oral cyclosporine was more effective than betamethasone minipulse therapy for treating Alopecia Areata, with more patients in the cyclosporine group showing excellent and good responses compared to the betamethasone group. Our plain-language summary of this paper — not a Tressless recommendation.
In 2019, a study was conducted on 56 cases of Alopecia Areata (AA), an autoimmune condition causing non-scarring hair loss, to compare the effectiveness of cyclosporine and betamethasone minipulse therapy. The patients were divided into two groups of 28 each, with Group I receiving oral cyclosporine and Group II receiving betamethasone minipulse therapy. The results showed that 8 cases in Group I and 4 in Group II had an excellent response, 12 in Group I and 6 in Group II had a good response, 5 in Group I and 12 in Group II had a fair response, and 3 in Group I and 6 in Group II had a poor response. The study concluded that oral cyclosporine was more effective than betamethasone minipulse therapy in treating AA.
